LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration (AMD)
SEATTLE--(BUSINESS WIRE)-- #DryAMD--LumiThera Initiates EUROLIGHT Registry Study to Evaluate Long-term Benefits of Valeda® Treatments in Dry Age-Related Macular Degeneration Patients.